期刊文献+

妊娠合并肺动脉高压患者不同程度肺动脉高压与妊娠结局临床分析 被引量:1

Clinical analysis of the effects of abnormal pulmonary artery hypertension during pregnancy on pregnancy outcomes
原文传递
导出
摘要 目的探讨妊娠合并肺动脉高压(PAH)患者的妊娠结局。方法回顾性分析2006年1月至2020年12月河北医科大学第二医院收治的妊娠合并PAH 193例患者的临床资料。采用心脏彩色多普勒超声测定肺动脉收缩压,分为轻度组42例(肺动脉收缩压30~49 mmHg),中度组75例(肺动脉收缩压50~79 mmHg),重度组76例(肺动脉收缩压≥80 mmHg),比较各组肺动脉高压的病因、心功能及母儿结局。结果(1)193例患者中,先天性心脏115例(59.59%),肺动脉高压程度与患者心功能分级呈显著正相关(r=0.362,P<0.001);(2)重度组的早产发生率(53.16%,48/76)、低体质量儿率(37.68%,26/69)、新生儿窒息率(14.5%,10/69)、孕妇及新生儿转ICU率(77.63%,59/76;72.46%,50/69)、孕妇死亡率(8.81%,17/193),均高于轻度组(P<0.05);(3)影响孕产妇预后的相关因素分析显示,患者不规律产前检查(P=0.006)、重度肺动脉高压(P<0.001)、心功能不全(P=0.003)、全麻(P<0.001)是影响患者妊娠结局的因素。结论妊娠合并PAH严重威胁母儿生命。 Objective To analyze the effects of different degree of pulmonary arterial hypertension(PAH during pregnancy on pregnancy outcomes.Methods Clinical data of 193 women with pulmonary arterial hypertension was collected from January 2006 to December 2020 in The Second Hospital of Hebei Medical University and they were divided into three groups on the basis of pulmonary arterial pressure.42 cases of slight group(30~49 mmHg),75cases of moderate group(50~79 mmHg),and 76 cases of severe group(≥80mmHg).The cause,cardiac functional status(New York heart association,NYHA)and outcomes of maternal and infant were compared among the groups.Results(1)Among the 193 cases,115 cases were diagnosed as Congenital heart disease,accounting for 59.59%.There were positive corelations between the degree of pulmonary artery hypertension and cardiac functional status(r=0.362,P<0.001).(2)The rate of prematurity was 53.16%(48/76),low birth weight infant 37.68%(26/69),apnoea neonatorum 14.5%(10/69),The rates of pregnant women and neonates transferred to ICU were respectively 77.63%(59/76)and 72.46%(50/69),and the maternal mortality rate was 8.81%(17/193),which were significantly higher in severe group than those in gentle group(P<0.05);(3)Analysis of the the clinical factors affecting survival for PAH during pregnancy:irregular prenatal examination(P=0.006),severe pulmonary artery height(P<0.001),cardiac dysfunction(P=0.003),general anesthesia(P<0.001)significantly affected the survival of patient.Conclusion Pregnancy complicated with PAH is a serious threat to the lives of mothers and children.
作者 王成书 祁国红 孙艳 贾雯 祝翯 WANG Chengshu;QI Guohong;SUN Yan;JIA Wen;ZHU He(Department of Obstetrics,The Second Hospital of Hebei Medical University,Shijiazhuang,Hebei 050052,China)
出处 《中国妇产科临床杂志》 CSCD 2022年第4期398-401,共4页 Chinese Journal of Clinical Obstetrics and Gynecology
关键词 妊娠并发症 肺性高血压 妊娠结局 complications of pregnancy pulmonary arterial hypertension pregnancy outcome
  • 相关文献

参考文献4

二级参考文献42

  • 1Barst RJ,Langleben D,Badesch D,菅鑫妍.使用选择性内皮素A受体拮抗剂sitaxsentan治疗肺动脉高压[J].中国处方药,2006,5(8):29-29. 被引量:38
  • 2Evangelista A, Avegliano G, Aguilar R, et al. Impact of contrast-enhanced echocardiography on the diagnostic algorithm of acute aortic dissection[J]. Eur Heart J, 2010,31(4): 472-479.
  • 3ACOG Committee on Obstetric Praetiee. ACOG Committee Opinion. Number 299, September 2004 (replaces No. 158, September 1995). Guidelines for diagnostic imaging during pregnancy[J]. Obstet Gynecol, 2004, 1 04(3):647-651.
  • 4Kampman MA, Balei A, van Veldhuisen DJ, et al. N-terminal pro-B-type natriuretie peptide predicts cardiovascular complications in pregnant women with congenital heart disease [J]. Eur Heart J, 2014,35(11):708-715.
  • 5European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC) [J]. Eur Heart J. 2011,32(24):3147-3197.
  • 6Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease[J]. Circulation, 2001,104(5):515-521.
  • 7Drenthen W, Boersma E, Balei A, et al. Predictors of pregnancy complications in women with congenital heart disease[J]. Eur Heart J, 2010,31(17):2124-2132.
  • 8Hurst JW. The value of using the entire New York Heart Association' s classificationof heart and vascular disease[J]. Clin C ardiol, 2006, 29(9):415-417.
  • 9Mukoyama M, Nakao K, Hosodo K, et al. Brain natriureticpeptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide[J]. J Clin Invest, 1991, 87(4):1402-1412.
  • 10Kim SW, Park SW, Lira SH, et al. Amount of left ventrieular hypertrophy determines the plasma N-terminal pro-brain natriuretic peptide level in patients with hypertrophic cardiomyopathy and normal left ventricular ejection fraction [J]. Clin Cardiol, 2006,29(4):155-160.

共引文献359

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部